# Non-Invasive Alzheimer's Therapies Cognito Therapeutics Presents Its Non-Invasive Device Therapy By Kalin Ned | Published 2025-12-03 | Tech Source: Trend Hunter, https://www.trendhunter.com/trends/noninvasive-device-therapy References: [businesswire](https://www.businesswire.com/news/home/20251203036894/en/Cognito-Therapeutics-Announces-Presentation-of-New-CSF-Proteomic-and-EEG-Biomarker-Data-for-Spectris-in-Alzheimers-Disease-at-CTAD-2025)  The medical technology firm Cognito Therapeutics has presented new research findings at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) conference concerning its experimental non-invasive device therapy for Alzheimer's disease. This innovation is dubbed Spectris™. The presented data, which was derived from two separate studies, indicates that use of the device was associated with measurable biochemical changes in cerebrospinal fluid, specifically an increase in a protein linked to synaptic health and plasticity, alongside alterations in other proteins involved in neural protection. Additionally, electroencephalogram readings from a clinical trial suggested the non-invasive device therapy may slow the progression of certain brain wave patterns characteristic of the disease. Christian Howell, CEO, Cognito Therapeutics, confirmed: “The data presented at CTAD strengthen the biological foundation behind Spectris™ and show that a non-invasive, at-home therapy can engage pathways central to brain resilience and health." Image Credit: Cognito Therapeutics ## Trend Insights (Trend Hunter) - Score: 6.4/10 - Popularity: 61% | Activity: 74% | Freshness: 57% - Audience gender: 50% men, 50% women - Primary generations: Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [Gadgets](https://www.trendhunter.com/gadgets) ## Key Themes ### What's Driving This Trend - **Non-invasive Neuromodulation:** Emerging non-invasive therapies offer innovative neuromodulation techniques that target neurological diseases like Alzheimer’s without the need for surgical intervention. - **Home-based Health Devices:** Portable and at-home health devices are transforming patient care by providing continuous treatment in a familiar and comfortable setting, making healthcare more accessible. - **Biochemical Biomarker Monitoring:** Advancements in monitoring biochemical markers in cerebrospinal fluid are enhancing our understanding of synaptic health and neural protection, paving the way for precision medicine. ### Who This Affects Most - **Medical Technology:** The medical technology industry is witnessing a revolution with the development of devices that leverage non-invasive methods to treat chronic neurological conditions. - **Home Healthcare:** The home healthcare sector is evolving as new technologies enable patients to receive treatment in the comfort of their own homes, increasing convenience and compliance. - **Biotech and Pharmaceuticals:** Biotech and pharmaceutical companies are increasingly focusing on biomarker-driven strategies to develop targeted therapies that improve patient outcomes in neurological diseases. ## Related on Trend Hunter - [Revolutionary Medical Imaging Systems](https://www.trendhunter.com/trends/medical-imaging-systems.md) - [AI-Powered Home Therapy Booths](https://www.trendhunter.com/trends/home-therapy-booth.md) - [Surgically-Implanted Brain Computers](https://www.trendhunter.com/trends/neuralinks.md) - [AI-Powered Smart Sleep Headbands](https://www.trendhunter.com/trends/aipowered-smart-sleep-headband.md) - [Cognitive Health Management Programs](https://www.trendhunter.com/trends/brain-protection-program.md) - [Dementia Diagnosis-Focused Collaborations](https://www.trendhunter.com/trends/dementia-diagnosis.md) - [Brain Health Crowdfunding Campaigns](https://www.trendhunter.com/trends/crowdfunding-campaign1.md) - [Social Skills Trainers](https://www.trendhunter.com/trends/the-cognity-ai.md) - [Non-Invasive Muscle Activation Technologies](https://www.trendhunter.com/trends/muscle-activations.md)